Jubilant Pharmova Ltd reported a 5% year-on-year increase in total income to Rs. 1,774 Cr. for Q2FY25, with a 65% rise in normalized PAT to Rs. 103 Cr., and announced a strategic partnership with Pierre Fabre to acquire 80% of a new company in France.